BioSyent Inc. (RX.V)
CAD 11.64
(-0.94%)
CAD 11.64
(-0.94%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.76 Million CAD | -4.96% |
| 2022 | 7.12 Million CAD | 26.91% |
| 2021 | 5.61 Million CAD | -17.16% |
| 2020 | 6.77 Million CAD | 31.03% |
| 2019 | 5.17 Million CAD | 44.32% |
| 2018 | 3.58 Million CAD | 23.89% |
| 2017 | 2.89 Million CAD | 14.69% |
| 2016 | 2.52 Million CAD | 2.64% |
| 2015 | 2.45 Million CAD | -1.14% |
| 2014 | 2.48 Million CAD | 100.89% |
| 2013 | 1.23 Million CAD | 52.07% |
| 2012 | 813.36 Thousand CAD | 92.57% |
| 2011 | 422.37 Thousand CAD | 64.88% |
| 2010 | 256.17 Thousand CAD | 82.07% |
| 2009 | 140.7 Thousand CAD | -50.17% |
| 2008 | 282.36 Thousand CAD | 50.57% |
| 2007 | 187.53 Thousand CAD | -18.18% |
| 2006 | 229.2 Thousand CAD | 7.47% |
| 2005 | 213.27 Thousand CAD | -31.8% |
| 2004 | 312.71 Thousand CAD | 87.79% |
| 2003 | 166.52 Thousand CAD | 59.78% |
| 2002 | 104.22 Thousand CAD | -91.78% |
| 2001 | 1.26 Million CAD | 31.5% |
| 2000 | 964.15 Thousand CAD | 20.52% |
| 1999 | 800 Thousand CAD | 60.0% |
| 1998 | 500 Thousand CAD | -16.67% |
| 1997 | 600 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 5.44 Million CAD | -19.57% |
| 2024 Q2 | 6.06 Million CAD | 11.31% |
| 2023 Q3 | 6.84 Million CAD | 6.25% |
| 2023 Q4 | 6.76 Million CAD | -1.11% |
| 2023 Q1 | 5.32 Million CAD | -25.18% |
| 2023 FY | 6.76 Million CAD | -4.96% |
| 2023 Q2 | 6.44 Million CAD | 20.89% |
| 2022 Q4 | 7.12 Million CAD | 18.32% |
| 2022 Q2 | 5.25 Million CAD | -10.08% |
| 2022 Q3 | 6.01 Million CAD | 14.61% |
| 2022 FY | 7.12 Million CAD | 26.91% |
| 2022 Q1 | 5.84 Million CAD | 4.08% |
| 2021 Q1 | 5.5 Million CAD | -18.8% |
| 2021 FY | 5.61 Million CAD | -17.16% |
| 2021 Q3 | 6.99 Million CAD | 26.36% |
| 2021 Q2 | 5.53 Million CAD | 0.59% |
| 2021 Q4 | 5.61 Million CAD | -19.74% |
| 2020 Q1 | 5.48 Million CAD | 6.17% |
| 2020 FY | 6.77 Million CAD | 31.03% |
| 2020 Q3 | 5.75 Million CAD | 5.45% |
| 2020 Q2 | 5.46 Million CAD | -0.52% |
| 2020 Q4 | 6.77 Million CAD | 17.65% |
| 2019 Q3 | 4.63 Million CAD | 43.08% |
| 2019 Q4 | 5.17 Million CAD | 11.6% |
| 2019 Q2 | 3.23 Million CAD | 5.92% |
| 2019 Q1 | 3.05 Million CAD | -14.67% |
| 2019 FY | 5.17 Million CAD | 44.32% |
| 2018 Q3 | 2.81 Million CAD | -9.97% |
| 2018 Q4 | 3.58 Million CAD | 27.13% |
| 2018 FY | 3.58 Million CAD | 23.89% |
| 2018 Q1 | 2.49 Million CAD | -13.86% |
| 2018 Q2 | 3.13 Million CAD | 25.66% |
| 2017 FY | 2.89 Million CAD | 14.69% |
| 2017 Q2 | 2.36 Million CAD | 13.16% |
| 2017 Q3 | 2.28 Million CAD | -3.21% |
| 2017 Q4 | 2.89 Million CAD | 26.44% |
| 2017 Q1 | 2.08 Million CAD | -17.19% |
| 2016 Q4 | 2.52 Million CAD | 45.7% |
| 2016 FY | 2.52 Million CAD | 2.64% |
| 2016 Q3 | 1.73 Million CAD | -18.74% |
| 2016 Q1 | 1.51 Million CAD | -38.49% |
| 2016 Q2 | 2.12 Million CAD | 40.95% |
| 2015 Q4 | 2.45 Million CAD | 23.48% |
| 2015 Q1 | 1.69 Million CAD | -31.97% |
| 2015 Q2 | 1.84 Million CAD | 9.06% |
| 2015 Q3 | 1.98 Million CAD | 7.9% |
| 2015 FY | 2.45 Million CAD | -1.14% |
| 2014 Q4 | 2.48 Million CAD | 37.39% |
| 2014 Q2 | 1.29 Million CAD | 33.63% |
| 2014 Q3 | 1.8 Million CAD | 39.22% |
| 2014 FY | 2.48 Million CAD | 100.89% |
| 2014 Q1 | 972.09 Thousand CAD | -21.41% |
| 2013 FY | 1.23 Million CAD | 52.07% |
| 2013 Q3 | 1.29 Million CAD | -2.48% |
| 2013 Q4 | 1.23 Million CAD | -4.46% |
| 2013 Q1 | 733.47 Thousand CAD | -9.82% |
| 2013 Q2 | 1.32 Million CAD | 81.0% |
| 2012 Q4 | 813.36 Thousand CAD | -28.48% |
| 2012 Q3 | 1.13 Million CAD | 39.14% |
| 2012 Q2 | 817.28 Thousand CAD | 29.63% |
| 2012 FY | 813.36 Thousand CAD | 92.57% |
| 2012 Q1 | 630.49 Thousand CAD | 49.28% |
| 2011 FY | 422.37 Thousand CAD | 64.88% |
| 2011 Q4 | 422.37 Thousand CAD | -37.77% |
| 2011 Q3 | 678.75 Thousand CAD | 69.12% |
| 2011 Q2 | 401.34 Thousand CAD | 40.0% |
| 2011 Q1 | 286.67 Thousand CAD | 11.91% |
| 2010 Q4 | 256.17 Thousand CAD | -9.43% |
| 2010 FY | 256.17 Thousand CAD | 82.07% |
| 2010 Q1 | 136.76 Thousand CAD | -2.8% |
| 2010 Q2 | 178.49 Thousand CAD | 30.51% |
| 2010 Q3 | 282.83 Thousand CAD | 58.46% |
| 2009 Q4 | 140.7 Thousand CAD | -44.4% |
| 2009 Q2 | 144.55 Thousand CAD | -39.35% |
| 2009 Q3 | 253.04 Thousand CAD | 75.05% |
| 2009 FY | 140.7 Thousand CAD | -50.17% |
| 2009 Q1 | 238.36 Thousand CAD | -15.58% |
| 2008 Q2 | 202.98 Thousand CAD | -3.4% |
| 2008 Q3 | 285.27 Thousand CAD | 40.54% |
| 2008 Q4 | 282.36 Thousand CAD | -1.02% |
| 2008 FY | 282.36 Thousand CAD | 50.57% |
| 2008 Q1 | 210.13 Thousand CAD | 12.05% |
| 2007 Q2 | 195.63 Thousand CAD | -29.71% |
| 2007 Q1 | 278.32 Thousand CAD | 21.43% |
| 2007 FY | 187.53 Thousand CAD | -18.18% |
| 2007 Q4 | 187.53 Thousand CAD | -37.14% |
| 2007 Q3 | 298.33 Thousand CAD | 52.5% |
| 2006 FY | 229.2 Thousand CAD | 7.47% |
| 2006 Q1 | 217.78 Thousand CAD | 2.11% |
| 2006 Q3 | 305.75 Thousand CAD | 43.53% |
| 2006 Q2 | 213.03 Thousand CAD | -2.18% |
| 2006 Q4 | 229.2 Thousand CAD | -25.04% |
| 2005 FY | 213.27 Thousand CAD | -31.8% |
| 2005 Q2 | 253.03 Thousand CAD | 36.36% |
| 2005 Q1 | 185.56 Thousand CAD | -40.66% |
| 2005 Q3 | 218.95 Thousand CAD | -13.47% |
| 2005 Q4 | 213.27 Thousand CAD | -2.59% |
| 2004 Q4 | 312.71 Thousand CAD | 7.06% |
| 2004 Q3 | 292.08 Thousand CAD | -0.66% |
| 2004 Q2 | 294.01 Thousand CAD | 5.09% |
| 2004 Q1 | 279.78 Thousand CAD | 68.01% |
| 2004 FY | 312.71 Thousand CAD | 87.79% |
| 2003 Q4 | 166.52 Thousand CAD | -27.29% |
| 2003 FY | 166.52 Thousand CAD | 59.78% |
| 2003 Q3 | 229.04 Thousand CAD | -20.59% |
| 2003 Q2 | 288.43 Thousand CAD | 60.85% |
| 2003 Q1 | 179.32 Thousand CAD | 72.06% |
| 2002 FY | 104.22 Thousand CAD | -91.78% |
| 2002 Q1 | 189.98 Thousand CAD | -85.02% |
| 2002 Q2 | 205.92 Thousand CAD | 8.39% |
| 2002 Q3 | 244.59 Thousand CAD | 18.78% |
| 2002 Q4 | 104.22 Thousand CAD | -57.39% |
| 2001 Q3 | 1.21 Million CAD | 12.43% |
| 2001 Q4 | 1.26 Million CAD | 4.33% |
| 2001 FY | 1.26 Million CAD | 31.5% |
| 2001 Q1 | 990.11 Thousand CAD | 2.69% |
| 2001 Q2 | 1.08 Million CAD | 9.17% |
| 2000 Q4 | 964.15 Thousand CAD | -6.5% |
| 2000 FY | 964.15 Thousand CAD | 20.52% |
| 2000 Q2 | 1 Million CAD | 0.0% |
| 2000 Q3 | 1.03 Million CAD | 3.12% |
| 2000 Q1 | 1 Million CAD | 25.0% |
| 1999 FY | 800 Thousand CAD | 60.0% |
| 1999 Q1 | 500 Thousand CAD | 0.0% |
| 1999 Q3 | 900 Thousand CAD | 0.0% |
| 1999 Q4 | 800 Thousand CAD | -11.11% |
| 1999 Q2 | 900 Thousand CAD | 80.0% |
| 1998 Q2 | 200 Thousand CAD | -60.0% |
| 1998 Q3 | 200 Thousand CAD | 0.0% |
| 1998 Q1 | 500 Thousand CAD | -16.67% |
| 1998 Q4 | 500 Thousand CAD | 150.0% |
| 1998 FY | 500 Thousand CAD | -16.67% |
| 1997 FY | 600 Thousand CAD | 0.0% |
| 1997 Q3 | 300 Thousand CAD | 0.0% |
| 1997 Q4 | 600 Thousand CAD | 100.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.38 Million CAD | -25.82% |
| CanadaBis Capital Inc. | 15.61 Million CAD | 56.66% |
| Decibel Cannabis Company Inc. | 96.79 Million CAD | 93.006% |
| Delivra Health Brands Inc. | 4.85 Million CAD | -39.341% |
| Entourage Health Corp. | 178.68 Million CAD | 96.212% |
| Lifeist Wellness Inc. | 9.94 Million CAD | 31.904% |
| Cannara Biotech Inc. | 61.77 Million CAD | 89.043% |
| Medicure Inc. | 8.16 Million CAD | 17.075% |
| PharmaCielo Ltd. | 23.96 Million CAD | 71.759% |
| Rubicon Organics Inc. | 16.99 Million CAD | 60.174% |
| Voyageur Pharmaceuticals Ltd. | 727.87 Thousand CAD | -829.99% |